ReviewFrontiers in pharmacology2026

Mitochondrial dysfunction in Alzheimer's disease: targeting the powerhouse with nanomedicine.

Chen Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.